查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球經前綜合症 (PMS) 藥物市場 (2022-2030)：增長、未來展望、競爭對手分析
市場調查報告書
商品編碼
1182394

全球經前綜合症 (PMS) 藥物市場 (2022-2030)：增長、未來展望、競爭對手分析

Pre-Menstrual Syndrome Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

由於 PMS 患病率的增加以及對 PMS 和常見治療方案的認識不斷提高，目前經前綜合症 (PMS) 藥物市場由北美和歐洲主導。. 另一方面，亞太和中東及非洲地區為 PMS 療法製造商提供了有利可圖的機會。 大量的育齡婦女以及不斷提高的識字率和工作人口極大地促進了這些地區商業機會的擴大。 此外，越來越多的政府舉措和活動以婦女和孕產婦健康為重點，進一步推動了市場增長。

本報告調查了全球經前綜合症 (PMS) 藥物市場，提供了市場概況、對市場增長的各種影響因素的分析、市場規模、各個細分市場、地區和主要國家的趨勢和預測。我們單獨編制了一份報告細目分類、主要公司概況等。

內容

第一章前言

第 2 章執行摘要

第 3 章經前綜合症 (PMS) 藥物市場：競爭分析

  • 供應商在市場中的地位
  • 供應商招聘策略
  • 主要行業戰略
  • 等級分析：2021/2030

第 4 章經前綜合症 (PMS) 藥物市場：宏觀分析和市場動態

  • 世界市場規模：2020-2030
  • 市場動態
    • 市場驅動因素
    • 市場製約因素
    • 主要問題
    • 主要機會
  • 促進因素和製約因素的影響分析
  • 蹺蹺板分析

第 5 章經前綜合症 (PMS) 藥物市場：按藥物類型分類

  • 市場概覽
  • 增長/利潤分析：2021/2030
  • 市場分類
    • 止痛藥（止痛藥）
    • 口服避孕藥 (OCP)
    • 促性腺激素釋放激素 (GnRH)
    • 抗抑鬱藥
    • 卵巢抑製劑
    • 利尿劑
    • 苯二氮卓類

第 6 章北美經前綜合症 (PMS) 藥物市場

  • 市場概覽
  • 經前綜合症 (PMS) 藥物市場：按藥物類型分類
  • 經前綜合症 (PMS) 藥物市場：按地區

第 7 章英國和歐盟的經前綜合症 (PMS) 藥物市場

  • 市場概覽
  • 經前綜合症 (PMS) 藥物市場：按藥物類型分類
  • 經前綜合症 (PMS) 藥物市場：按地區

第 8 章亞太經前綜合症 (PMS) 藥物市場

  • 市場概覽
  • 經前綜合症 (PMS) 藥物市場：按藥物類型分類
  • 經前綜合症 (PMS) 藥物市場：按地區

第 9 章。拉丁美洲經前綜合症 (PMS) 藥物市場

  • 市場概覽
  • 經前綜合症 (PMS) 藥物市場：按藥物類型分類
  • 經前綜合症 (PMS) 藥物市場：按地區

第 10 章中東和非洲的經前綜合症 (PMS) 藥物市場

  • 市場概覽
  • 經前綜合症 (PMS) 藥物市場：按藥物類型分類
  • 經前綜合症 (PMS) 藥物市場：按地區

第11章公司簡介

  • Alva-Amco Pharmacal Cos., Inc.
  • Bayer, Inc.
  • Chattem, Inc.（Sanofi）
  • DEKK-TEC, Inc.
  • G. R. Lane Health Products Ltd
  • McNeil Consumer Healthcare
  • MetP Pharma AG
  • Pherin Pharmaceuticals, Inc.
  • Umecrine Mood AB
  • Umecrine Mood AB
  • Novartis AG
  • GlaxoSmithKline Plc
Product Code: 137381-08-22

Pre-menstrual syndrome (PMS) is a medical condition in women that occurs during childbearing age. It is estimated that more than one in three women suffer from PMS; and one in every twenty women demonstrate life disturbing symptoms. Pre-menstrual dysphoric disorder (PMDD) is a further severe form of PMS and demonstrates more severe symptoms of PMS, often interfering with social activities, work and emotional balance. PMDD occurs in 3% to 5% of menstruating women. Though the exact cause of PMS is unknown, it is reported that fluctuating levels of hormones (estrogen and progesterone) are related to PMS symptoms. The treatment regimen of PMS is temporary i.e. administered only for symptom management before the onset of menstrual cycle. Education, nutrition, exercise and medication together form the complete layout of PMS treatment module.

The report titled "Pre-menstrual Syndrome Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022-2030" offers strategic insights into the overall pre-menstrual syndrome treatment market along with the market size and estimates for the duration 2020 to 2030. The said research study covers in-depth analysis of multiple market segments based on type of drugs and different geographies. The drug types studied for analyzing the overall global pre-menstrual syndrome treatment market are majorly segmented into analgesics (pain killers), oral contraceptive pills (OCPs), gonadotropin-releasing hormone (GnRH), antidepressants, ovarian suppressors, diuretics and benzodiazepines.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global pre-menstrual syndrome treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global pre-menstrual syndrome treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global pre-menstrual syndrome treatment market. In-depth competitive environment analysis and historical (2020) market size data are also provided in the report.

Common painkillers available for treating PMS are NSAIDS and paracetamol. This segment is majorly dominated by over-the-counter drugs that are cheap and easily available in the market. For depression and anxiety, particularly in patients with PMDD, drugs such as SSRIs (commonly fluoxetine and sertraline) are commonly prescribed. GnRH i.e. synthetic hormones are prescribed to initiate temporary menopause in patients with severe PMS. It is observed that the demand for hormone-based PMS treatments is on a perpetual rise and will continue through the forecast period.

At present, North America and Europe dominate the premenstrual syndrome treatment market due to increase in prevalence of premenstrual syndrome and higher awareness about syndrome and prevailing treatment options. Asia Pacific and Middle East and Africa together present lucrative opportunities to manufacturers offering PMS treatment drugs. Large pool of females in childbearing age, growing literacy rate and working population significantly contribute to growing opportunities in the region. Growing number of government initiatives and campaigns focusing on women and maternity health are further driving the market growth.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Pre-Menstrual Syndrome Treatment market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Pre-Menstrual Syndrome Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Drugs Type

  • Analgesics (pain killers)
  • Oral Contraceptive Pills (OCPs)
  • Gonadotropin-releasing Hormone (GnRH)
  • Antidepressants
  • Ovarian Suppressors
  • Diuretics
  • Benzodiazepines

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Pre-Menstrual Syndrome Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Pre-Menstrual Syndrome Treatment market?
  • Which is the largest regional market for Pre-Menstrual Syndrome Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Pre-Menstrual Syndrome Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Pre-Menstrual Syndrome Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Pre-Menstrual Syndrome Treatment Market
  • 2.2. Global Pre-Menstrual Syndrome Treatment Market, By Drugs Type, 2021 (US$ Million)
  • 2.3. Global Pre-Menstrual Syndrome Treatment Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Pre-Menstrual Syndrome Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Pre-Menstrual Syndrome Treatment Market Vendors
  • 3.2. Strategies Adopted by Pre-Menstrual Syndrome Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Pre-Menstrual Syndrome Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Pre-Menstrual Syndrome Treatment Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Analgesics (pain killers)
    • 5.3.2. Oral Contraceptive Pills (OCPs)
    • 5.3.3. Gonadotropin-releasing Hormone (GnRH)
    • 5.3.4. Antidepressants
    • 5.3.5. Ovarian Suppressors
    • 5.3.6. Diuretics
    • 5.3.7. Benzodiazepines

6. North America Pre-Menstrual Syndrome Treatment Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
  • 6.3.Pre-Menstrual Syndrome Treatment Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

7. UK and European Union Pre-Menstrual Syndrome Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
  • 7.3.Pre-Menstrual Syndrome Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

8. Asia Pacific Pre-Menstrual Syndrome Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
  • 8.3.Pre-Menstrual Syndrome Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

9. Latin America Pre-Menstrual Syndrome Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
  • 9.3.Pre-Menstrual Syndrome Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

10. Middle East and Africa Pre-Menstrual Syndrome Treatment Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
  • 10.3.Pre-Menstrual Syndrome Treatment Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Pre-Menstrual Syndrome Treatment Market: By Drugs Type, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. Alva-Amco Pharmacal Cos., Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Bayer, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Chattem, Inc. (Sanofi)
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. DEKK-TEC, Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. G. R. Lane Health Products Ltd
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. McNeil Consumer Healthcare
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. MetP Pharma AG
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Pherin Pharmaceuticals, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Umecrine Mood AB
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Umecrine Mood AB
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Novartis AG
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives
  • 11.12. GlaxoSmithKline Plc
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Portfolio
    • 11.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 2 North America Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 3 U.S. Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 4 Canada Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 5 Rest of North America Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 7 UK Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 8 Germany Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 9 Spain Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 10 Italy Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 11 France Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 12 Rest of Europe Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 13 Asia Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 14 China Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 15 Japan Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 16 India Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 17 Australia Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 18 South Korea Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 19 Latin America Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 20 Brazil Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 21 Mexico Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 22 Rest of Latin America Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 23 Middle East and Africa Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 24 GCC Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 25 Africa Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)
  • TABLE 26 Rest of Middle East and Africa Pre-Menstrual Syndrome Treatment Market By Drugs Type, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Pre-Menstrual Syndrome Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Pre-Menstrual Syndrome Treatment Market: Quality Assurance
  • FIG. 5 Global Pre-Menstrual Syndrome Treatment Market, By Drugs Type, 2021
  • FIG. 6 Global Pre-Menstrual Syndrome Treatment Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Pre-Menstrual Syndrome Treatment Market, 2021
  • FIG. 8 Market Positioning of Key Pre-Menstrual Syndrome Treatment Market Players, 2021
  • FIG. 9 Global Pre-Menstrual Syndrome Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Pre-Menstrual Syndrome Treatment Market, By Drugs Type, 2021 Vs 2030, %
  • FIG. 11 U.S. Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 France Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 China Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 India Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Pre-Menstrual Syndrome Treatment Market (US$ Million), 2020 - 2030